Phase II trial of pembrolizumab (P) in combination with sEphB4-HSA (B4) in previously treated metastatic urothelial carcinoma (mUC)

Authors
Category Primary study
JournalANNALS OF ONCOLOGY
Year 2021
This article has no abstract
Epistemonikos ID: 8046c73d5ced7f5d1f3ea20505bb503a1fb59578
First added on: Feb 13, 2025